Search Results - Rong Fu
- Showing 1 - 5 results of 5
-
1
Digital Transformation and Enterprise Innovation Capability: From the Perspectives of Enterprise Cooperative Culture and Innovative Culture by Tao Liu, Jiaxuan Leng, Shunyu Zhu, Rong Fu
Published 2025-06-01Enterprise digital transformation has emerged as a key strategy for enhancing innovation capacity in the age of the digital economy. This article aims to analyze the influence mechanism of digital transformation on corporate innovation and evaluate the mediating function of corporate innovation and...
Get full text
Article -
2
Budd-chiari syndrome associated with acute promyelocytic leukemia: a case and literature review by Honglei Wang, Jing Guan, Jia Zeng, Ting Wang, Xu Lang, Rong Fu
Published 2025-12-01Background Acute promyelocytic leukemia (APL) is prone to hemorrhage and thrombosis during onset and induction treatment. Occasionally, severe and rare thrombosis can occur, which deserves our attention. Such as Budd-Chiari syndrome (BCS). BCS is a rare and severe disease caused by occlusion of the...
Get full text
Article -
3
Comprehensive measurement of purines in biological samples by Rong Fu, Diane J. Sutcliffe, Ashok R. Dinasarapu, Ellen J. Hess, Ellen J. Hess, H. A. Jinnah, H. A. Jinnah
Published 2025-07-01Defects in numerous aspects of purine metabolism are well-recognized causes for human diseases. The applicability of ultra performance liquid chromatography (UPLC) with photodiode array (PDA) detection for analysis of the most abundant biological relevant purines metabolites is described. This metho...
Get full text
Article -
4
Phase I open-label study of the respiratory syncytial virus monoclonal antibody clesrovimab: Safety and tolerability in healthy Chinese participants by Yulei He, Fengli Zhao, Xiao Yang, Shasha Xing, Feifeng Xi, Fen Shen, Lin Yang, Guijun Ning, Fang Sun, Rui Wang, Qiong Shou, Rong Fu, Chang Chen, Anushua Sinha, Xueyan Liao
Published 2025-12-01In China, respiratory syncytial virus (RSV) is the primary cause of acute lower respiratory tract infections (LRTIs), particularly in infants and young children. Clesrovimab is a half-life‒extended RSV neutralizing monoclonal antibody for the prevention of RSV-associated LRTIs in infants. This Phase...
Get full text
Article -
5
Expert consensus on a multidisciplinary approach for the management of multiple myeloma-related bone disease by Yutong Wang, Qiming Xu, Yuan Li, Yongbin Su, Ling Wang, Xiaoquan Wang, Jian Ge, Hongmei Jing, Yuxing Guo, Yalin Chen, Xianan Li, Jun-ling Zhuang, Jing Tan, Xiaobo Wang, Liye Zhong, Jun Luo, Peng Zhao, Shengjin Fan, Jinhai Ren, Haiping Yang, Heng Mei, Chunyan Sun, Chunrui Li, Xuemei Sun, Xuechun Lu, Guangxun Gao, Zeping Zhou, Yaozhu Pan, Ying Sun, Zhang Hong, Zhiqiang Liu, Yanping Ma, Yi Wang, Wei Sun, Jian Hou, Jianqing Mi, Wenming Chen, Xiaobing Huang, Bingzong Li, Rong Fu, Jumei Shi, Xuehong Ran, Fuling Zhou, Aili He, Min Mao, Zhen Cai, Nan Li, Meng Xu, Xiaojing Yan, Wei Yang, Gang An, Lihua Gong, Lichao Sun, Zhihong Li, Tang Liu, Yanjuan He, Junqiang Yin, Yao Liu, Weifeng Liu, Li Bao
Published 2025-07-01This consensus on multiple myeloma-related bone diseases (MBDs) underscores the importance of a multidisciplinary approach that encompasses hematology, radiology, orthopedics, and additional specialties to tackle its intricate challenges. MBD, a prevalent and debilitating complication of multiple my...
Get full text
Article